All DMARD patients need hepatitis screening.(RHEUMATOLOGY)(disease-modifying antirheumatic drug)(Report): An article from: Internal Medicine News

This digital document is an article from Internal Medicine News, published by International Medical News Group on April 1, 2010. The length of the article is 891 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: All DMARD patients need hepatitis screening.(RHEUMATOLOGY)(disease-modifying antirheumatic drug)(Report)
Author: Bruce Jancin
Publication:Internal Medicine News (Magazine/Journal)
Date: April 1, 2010
Publisher: International Medical News Group
Volume: 43 Issue: 6 Page: 48(2)

Article Type: Report

Distributed by Gale, a part of Cengage Learning